
Biogen appoints Adam Keeney to run business development activities
Biogen has a new face of BD.
Adam Keeney joins the company as head of corporate development, Biogen announced Tuesday morning, following a four-year stint as CEO of UK biotech NodThera. Keeney will “focus on advancing the company’s strategy and pursuing external collaborations and other growth opportunities,” Biogen CEO Chris Viehbacher said in a statement.
Citing his start date of April 17, Keeney declined to comment Tuesday on his hiring.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.